Nuo Therapeutics Management
Management criteria checks 3/4
Nuo Therapeutics' CEO is David Jorden, appointed in May 2015, has a tenure of 8.92 years. total yearly compensation is $225.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 4.46% of the company’s shares, worth $1.58M. The average tenure of the management team and the board of directors is 7 years and 13.3 years respectively.
Key information
David Jorden
Chief executive officer
US$225.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 8.9yrs |
| CEO ownership | 4.5% |
| Management average tenure | 7yrs |
| Board average tenure | 13.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$225k | US$225k | -US$3m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | n/a | n/a | -US$4m |
| Dec 31 2022 | US$171k | US$169k | -US$3m |
| Sep 30 2022 | n/a | n/a | -US$3m |
| Jun 30 2022 | n/a | n/a | -US$2m |
| Mar 31 2022 | n/a | n/a | -US$1m |
| Dec 31 2021 | n/a | n/a | -US$886k |
| Sep 30 2021 | n/a | n/a | US$8m |
| Dec 31 2020 | US$55k | n/a | US$8m |
| Sep 30 2020 | n/a | n/a | US$201k |
| Dec 31 2019 | US$141k | US$92k | -US$1m |
| Sep 30 2019 | n/a | n/a | -US$884k |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | n/a | n/a | -US$2m |
| Dec 31 2018 | US$276k | US$275k | -US$2m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$11m |
| Mar 31 2018 | n/a | n/a | -US$14m |
| Dec 31 2017 | US$275k | US$275k | -US$15m |
Compensation vs Market: David's total compensation ($USD225.00K) is below average for companies of similar size in the US market ($USD670.12K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Jorden (61 yo)
8.9yrs
Tenure
US$225,000
Compensation
Mr. David E. Jorden, CPA has been the Chief Executive Officer and Chief Financial Officer of Nuo Therapeutics, Inc. since July 1, 2016 and serves as its Secretary and was its Acting Chief Executive Officer...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 8.9yrs | US$225.00k | 4.46% $ 1.6m | |
| COO & Chief Scientific Officer | 2.3yrs | US$225.00k | 1.3% $ 460.0k | |
| Informal Board Advisor | no data | US$27.50k | no data |
7.0yrs
Average Tenure
57yo
Average Age
Experienced Management: AURX's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 15.5yrs | US$225.00k | 4.46% $ 1.6m | |
| Independent Director | 15.3yrs | US$1.07k | 0.057% $ 20.0k | |
| Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
| Independent Director | 7yrs | US$1.07k | 0% $ 0 | |
| Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 13.3yrs | no data | no data | |
| Independent Director | 7.9yrs | US$1.43k | 11.4% $ 4.0m |
13.3yrs
Average Tenure
65.5yo
Average Age
Experienced Board: AURX's board of directors are seasoned and experienced ( 13.3 years average tenure).